Intel CEO Pat Gelsinger speaks with Bloomberg's Caroline Hyde and Ed Ludlow about their third quarter earnings, beating analysts expectations and provided an outlook for the fourth quarter, implying revenue growth for the first time in nearly three years.

Intel CEO Pat Gelsinger speaks with Bloomberg's Caroline Hyde and Ed Ludlow about their third quarter earnings, beating analysts expectations and provided an outlook for the fourth quarter, implying revenue growth for the first time in nearly three years.

Bloomberg Talks curates top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment. On Bloomberg Talks, we round up interviews with Fortune 500 CEOs, government officials, well-known investors and business leaders. 

Bloomberg Talks curates top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment. On Bloomberg Talks, we round up interviews with Fortune 500 CEOs, government officials, well-known investors and business leaders.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment. On Bloomberg Talks, we round up interviews with Fortune 500 CEOs, government officials, well-known investors and business leaders.

Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment. On Bloomberg Talks, we round up interviews with Fortune 500 CEOs, government officials, well-known investors and business leaders.

Intel CEO Pat Gelsinger Talks Outlook, PC Market

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ac53dfc4-450d-4298-8635-b0a8011a8d77/transcript

Apple shares jumped in late trading after the company posted stronger-than-expected sales last quarter and predicted a return to growth in the current period, sparking optimism that a slowdown is easing. The results came as a relief to investors, who have been waiting for the iPhone maker to pull out of a long slump.

Bloomberg TV and Radio hosts Carol Massar and Tim Stenovec speak with Bloomberg Intelligence Senior Technology Analyst Anurag Rana, Bloomberg News Chief Technology Correspondent Mark Gurman and Synovus Trust Senior Portfolio Manager Dan Morgan for analysis and reaction. 

Apple shares jumped in late trading after the company posted stronger-than-expected sales last quarter and predicted a return to growth in the current period, sparking optimism that a slowdown is easing. The results came as a relief to investors, who have been waiting for the iPhone maker to pull out of a long slump.
Bloomberg TV and Radio hosts Carol Massar and Tim Stenovec speak with Bloomberg Intelligence Senior Technology Analyst Anurag Rana, Bloomberg News Chief Technology Correspondent Mark Gurman and Synovus Trust Senior Portfolio Manager Dan Morgan for analysis and reaction.

Instant Reaction: Apple Beats on Sales and Earnings

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9de3f8cb-08b2-4dc6-95e4-b164015e61e1/transcript

Marker 01

Carvana reported earnings that beat estimates even as buyers are looking for better deals. Vehicle sales were up by 16%. CEO Ernie Garcia III says demand for electric cars is also ramping up. He spoke with Bloomberg's Romaine Bostick and Alix Steel

Carvana reported earnings that beat estimates even as buyers are looking for better deals. Vehicle sales were up by 16%. CEO Ernie Garcia III says demand for electric cars is also ramping up. He spoke with Bloomberg's Romaine Bostick and Alix Steel

Carvana CEO Ernie Garcia Talks EV Sales

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/462a58b4-f2e4-4dd3-ae77-b16401542237/transcript

Tempo: 150.0

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. 

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly &amp; Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick.

Novo Nordisk CEO Talks Weight Loss Drug Supply

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7a30995e-df80-4f8d-b9d2-b164014b2e58/transcript

Intel CEO Pat Gelsinger Talks Outlook, PC Market

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips